๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Hangzhou

1812 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
A Safety and Efficacy Trial of Chidamide Combined With NKG2D CAR-NK Cell Therapy for Reducing the HIV Viral Reservoir
NCT07577986HIV (Human Immunodeficiency Virus)
First Affiliated Hospital of Zhejiang University
Phase 1/2
20
Hangzhou
2026-05-01
Not yet open
Clinical Study on the Preservation of Ovarian Function Following Hematopoietic Stem Cell Transplantation in Patients With Malignant Hematologic Diseases Using Goserelin
NCT07552480Allogeneic Haematopoietic Stem Cell Transplantation, Malignant Hematologic Disease, Ovarian Insufficiency
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
64
Zhengzhou, Wuhan, Kunming, Hangzhou
2026-05-01
Not yet open
Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis
NCT07435051Osteomyelitis (Refractory)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
280
Hangzhou
2026-05-01
Not yet open
Effect of Episodic Future Thinking on Promoting Physical Activity Among Older Adults With Motoric Cognitive Risk Syndrome: A Randomized Controlled Trial
NCT07554027Physical Activities, Motoric Cognitive Risk Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
166
Hangzhou
2026-05
Not yet open
Dual-Label Intervention to Promote Low-Carbon and Healthy Food Choices in a University Cafeteria
NCT07531524Eating Behavior, Dietary Behavior
Lina Zhang
Not applicable
200
Hangzhou
2026-05
Not yet open
A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus
NCT07557927Discoid Lupus Erythematosus
Kunming Pharmaceuticals, Inc.
Phase 2
100
Hefei, Beijing, Chongqing, Guangzhou, Changsha, Shenyang, Kunming, Hangzhou
2026-04-30
Not yet open
Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
NCT07505095Alzheimer Disease (AD), Alzheimer Dementia, MCI-AD, Early Stage Alzheimer's Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
140
Hangzhou
2026-04-30
Recruiting
Neoadjuvant Treatment of Fulzerasib Plus Cetuximab N01 in KRAS G12C Mutated Locally Advanced Colorectal Cancer With or Without Resectable Metastases
NCT07581912Colorectal Cancer, KRAS G12C Mutant Advanced Solid Tumors, Fulzerasib, Cetuximab N01
Zhejiang University
Phase 2
40
Hangzhou
2026-04-30
Not yet open
A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis
NCT07549984Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
16
Hangzhou
2026-04-30
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
NCT07545772Irritable Bowel Syndrome, Constipation
Eli Lilly and Company
Phase 2
342
Binzhou, Chengdu, Guangzhou, Hangzhou, Hengyang, Huizhou, Huzhou, Meihekou
2026-04-29
Recruiting
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052Non-small Cell Lung Cancer (NSCLC)
Astellas Pharma Global Development, Inc.
Phase 3
356
Guangzhou, Hangzhou
2026-04-28
Recruiting
Research on the Efficacy and Safety of Targeted Suprachiasmatic Nucleus Electrical Stimulation for Improving Metabolic Disorders in Patients With Stable Bipolar Disorder Comorbid With Obesity
NCT07589647Bipolar Disorder (BD)
First Affiliated Hospital of Zhejiang University
Not applicable
70
Hangzhou
2026-04-27
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation for Preventing Acute Kidney Injury in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass
NCT07549243Acute Kidney Injury, Cardiac Surgery, Cardiopulmonary Bypass
Sir Run Run Shaw Hospital
Not applicable
152
Hangzhou
2026-04-27
Recruiting
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
NCT07303777Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management
Atom Therapeutics Co., Ltd
Phase 2
200
Beijing, Dalian, Guangzhou, Hangzhou, Jinan, Nanjing, Shanghai, Suzhou
2026-04-23
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
NCT07365995Metastatic Castration-resistant Prostate Cancer
BioNTech SE
Phase 3
736
Changsha, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Wenzhou, Wuhan
2026-04-22
Not yet open
Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks
NCT07496762Stroke Sequelae, Deglutition Disorders, Acupuncture Therapy, Electroacupuncture
Kaili Chen
Not applicable
90
Hangzhou
2026-04-21
Recruiting
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
NCT07483554CLDN18.2 Positive, Gastric/Gastroesophageal Junction Adenocarcinoma, Pancreatic Ductal Adenocarcinoma
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
389
Hangzhou
2026-04-20
Recruiting
CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.
NCT07538635High-risk R/R LBCL
Zhejiang Cancer Hospital
Phase 2
20
Hangzhou
2026-04-20
Recruiting
To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma
NCT07454187Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd.
Phase 1/2
40
Zhengzhou, Suzhou, Xiโ€™an, Hangzhou
2026-04-16
Recruiting
PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC
NCT07235319Nasopharangeal Cancer, Distant Metastasis
Sun Yat-sen University
Phase 3
260
Guangzhou, Changsha, Fuzhou, Hangzhou, Nanning
2026-04-16
Recruiting
Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage โ… -โ…ก MALT Lymphoma
NCT07554898MALT Lymphoma
Zhejiang Cancer Hospital
Phase 2
60
Hangzhou
2026-04-16
Recruiting
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
NCT07158242Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
100
Hangzhou, Shanghai
2026-04-15
Not yet open
Using Real-Time Lung Visuals to Reduce Mental Strain and Improve Diagnosis Speed
NCT07511712Mechanical Ventilation, Clinical Competence, Education Curriculum, Self Concept
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
34
Hangzhou
2026-04-15
Recruiting
Effects of Opioid Drugs on Sleep and Emotion in Patients With Moderate to Severe Cancer Pain
NCT07616648Moderate to Severe Cancer Pain
First Affiliated Hospital of Zhejiang University
Observational
200
Hangzhou
2026-04-15
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
Eli Lilly and Company
Phase 2
66
Beijing, Hangzhou, Shanghai, Shenzhen
2026-04-14
Recruiting
DAREON ยฎ -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim
Phase 3
670
Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-04-13
Recruiting
A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
NCT07511218Chronic Hepatitis B Infection
Ausper Biopharma Co., Ltd.
Phase 1
110
Chโ€™ang-chโ€™un, Hangzhou
2026-04-13
By invitation
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
NCT07240857Castration-Resistant Prostate Cancer (CRPC)
Zhejiang University
Phase EARLY_PHASE1
18
Hangzhou
2026-04-12
Recruiting
AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer
NCT07525765Gastrectomy for Gastric Cancer, Gastric Cancer
First Affiliated Hospital of Zhejiang University
Observational
7,000
Hangzhou
2026-04-10
Not yet open
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Cervical Epidural Injection for Cervical Radiculopathy
NCT07557823Cervical Radiculopathy, Cervical Spondylosis, Radicular Pain
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
80
Hangzhou
2026-04-10
Recruiting
Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC
NCT07365592Colorectal Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
138
Hangzhou
2026-04-09
Not yet open
Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
NCT07530133Indications for Laparoscopic Thoracic and Abdominal Surgery in Children, Congenital or Acquired Surgical Conditions Requiring Minimally Invasive Surgery in Children, Pyeloplasty, Ureteral Reimplantation
Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
Not applicable
64
Wuhan, Hangzhou, Wenzhou
2026-04-09
Recruiting
Westlake Frequent-sampling Cohort
NCT07460687Health Adults, Stability of Microbiome
Westlake University
Observational
20
Hangzhou
2026-04-08
Recruiting
Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries
NCT07501013Athletic Injuries (C26.857.500.124), Rotator Cuff Injuries, Tibial Meniscus Injuries, Shoulder Dislocation or Subluxation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
500
Hangzhou
2026-04-07
Not yet open
Bacteriophage Therapy for Orthopedic Implant-Associated Infections
NCT07533292Orthopedic, Implant Infection
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
100
Hangzhou
2026-04-05
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Recruiting
Grid eXplore Mapping Study
NCT07421076Paroxysmal Atrial Fibrillation (PAF)
Abbott Medical Devices
Not applicable
200
Jinan, Chengdu, Hangzhou, Ningbo, Beijing
2026-04-02
Not yet open
A Randomized, Double-blind, Placebo-controlled, Prospective, Multi-center Trial Evaluating the Improvement of Nutritional Status and Sarcopenia With Silkworm Pupa Tablets in Patients With Malignancies
NCT07554807Nutritional Deficiency, Gastrointestinal Cancers, Sarcopenia
First Affiliated Hospital of Zhejiang University
Phase 3
480
Hangzhou
2026-04-01
Recruiting
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
NCT07507201Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
15
Hangzhou
2026-04-01
Recruiting
Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma
NCT07164560Refractory/Recurrent Peripheral T-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
45
Hangzhou
2026-04-01
Recruiting
SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study
NCT07670013NSCLC
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
43
Hangzhou
2026-04-01
Not yet open
Effect of High-Flow Nasal Cannula Oxygen Therapy on Hypoxemia in Pediatric Sedated Bronchoscopy
NCT07563075Hypoxemia, Pneumonia, Pulmonary Neoplasm
Zhejiang University
Not applicable
430
Hangzhou, Wenzhou, Chongqing
2026-04-01
Not yet open
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
NCT07499154Congenital Heart Disease, Postoperative Pulmonary Complications, Acute Lung Injury
The Children's Hospital of Zhejiang University School of Medicine
Phase 4
320
Hangzhou
2026-04-01
Not yet open
Development and Validation of a Multimodal Artificial Intelligence Model for Early Prediction of Acute Myocardial Infarction
NCT07457320Myocardial Infarction
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
1,500
Hangzhou
2026-04-01
Recruiting
The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis
NCT07537426Facial Paralysis, Peripheral, Bell's Palsy, Ocular Surface Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
78
Hangzhou
2026-04-01
Not yet open
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
NCT07497074Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2
78
Guangzhou, Hangzhou
2026-04
Not yet open
Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS
NCT07457775Soft Tissue Sarcoma (Excluding GIST)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
24
Hangzhou
2026-03-31
Not yet open
Efficacy and Safety of Pegylated Interferon Alpha-2ฮฒ in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
NCT07553767Hepatocellular Carcinoma, HEPATITIS B CHRONIC, Hepatitis B Chronic Infection
Ningbo No.2 Hospital
Phase EARLY_PHASE1
156
Hangzhou, Ningbo
2026-03-31
Not yet open
Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)
NCT07507825Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou
Phase 2
61
Hangzhou
2026-03-31
Active, closed
A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors
NCT07749703Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
346
Hefei, Shenyang, Jinan, Shanghai, Hangzhou
2026-03-31
Recruiting
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
NCT07455734Advanced Solid Tumor Cancer
BioNTech SE
Phase 1/2
533
Chongqing, Guangzhou, Hangzhou, Shanghai, Tianjin
2026-03-30
Not yet open
Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular Carcinoma
NCT07487402Hepatocellular Carcinoma (HCC)
Zhejiang University
Phase EARLY_PHASE1
27
Hangzhou
2026-03-30
Recruiting
A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
NCT07405151Oesophageal Squamous Cell Carcinoma
Merck Sharp & Dohme LLC
Phase 1/2
60
Hefei, Beijing, Xiamen, Zhengzhou, Xuzhou, Jinan, Hangzhou
2026-03-27
Recruiting
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
NCT06968936Anemia, Iron Deficiencies, Cardiac Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
400
Hangzhou
2026-03-27
Recruiting
A Study of BGM0504 Tablets in Healthy Chinese Subjects
NCT07566572Chinese Healthy Volunteers
BrightGene Bio-Medical Technology Co., Ltd.
Phase 1
144
Hangzhou
2026-03-26
Recruiting
A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC
NCT07422753Hepatocellular Carcinoma (HCC)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
36
Hangzhou
2026-03-25
Not yet open
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
NCT07483749Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia
The Children's Hospital of Zhejiang University School of Medicine
Observational
400
Hangzhou, Ningbo
2026-03-25
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709Huntington Disease
Novartis Pharmaceuticals
Phase 3
770
Guangzhou, Wuhan, Changsha, Chengdu, Hangzhou
2026-03-24
Recruiting
DXP-106 in Solid Tumor Patients.
NCT07532018Solid Tumor, Cancer
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.
Phase 1
54
Harbin, Shanghai, Taiyuan, Hangzhou
2026-03-23
Recruiting
A Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer
NCT07454720Locally Advanced Resectable Rectal Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2/3
165
Wuhan, Hangzhou
2026-03-23
Not yet open
A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery
NCT07480044Postoperative Delirium (POD), Prostate Cancer, Kidney Tumor
Zhejiang University
Not applicable
220
Hangzhou
2026-03-20
Active, closed
Home Oscillatory Positive Expiratory Pressure - Aerobic Exercise Rehabilitation Study
NCT06970054COPD, AECOPD
Sir Run Run Shaw Hospital
Not applicable
312
Hangzhou
2026-03-20
Not yet open
Study on Serum Transcriptomics and Metabolomics in Patients With Diabetic Peripheral Neuropathy
NCT07518433Diabetic Peripheral Neuropathy (DPN), Pain
Zhejiang Chinese Medical University
Observational
90
Hangzhou
2026-03-20
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
NCT07490041Rheumatic Diseases, Pediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese), Systemic Lupus Erythematosus (SLE), Connective Tissue Disease-associated Interstitial Lung Disease
The Children's Hospital of Zhejiang University School of Medicine
Phase EARLY_PHASE1
36
Hangzhou
2026-03-19
Recruiting
Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer
NCT07416994Non-Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3
440
Shanghai, Hangzhou
2026-03-18
Not yet open
Decision-making and Optimization of Ventilatory Support for AECOPD Patients
NCT07508943Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Sir Run Run Shaw Hospital
Observational
1,000
Hangzhou
2026-03-18
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Recruiting
Group-based IMPROVE Therapy for Problematic Internet Use in University Students
NCT07434778Problematic Internet Use
Sir Run Run Shaw Hospital
Not applicable
600
Hangzhou
2026-03-17
Recruiting
Study to Assess Safety and Efficacy of HDP-101 in Chinese Patients With Relapsed or Refractory Multiple Myeloma
NCT07529782Multiple Myeloma and Other Plasma Cell Neoplasms
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
15
Beijing, Suzhou, Jinan, Tianjin, Hangzhou
2026-03-17
Recruiting
Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
NCT07498478Breast Cancer
TransThera Sciences (Nanjing), Inc.
Phase 2
94
Guangzhou, Wuhan, Changsha, Nanjing, Jinan, Linyi, Hangzhou, Beijing
2026-03-17
Recruiting
Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC)
NCT07501026Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
22
Hangzhou
2026-03-16
Not yet open
Video Double-Lumen Tube for Secondary Pulmonary Resection
NCT07467005Lung Cancer, Pulmonary Nodule
Zhejiang University
Not applicable
500
Hangzhou, Yiwu
2026-03-16
Recruiting
Chinese-Specific Speech Imagery Coding Using High-Density ECoG
NCT07460037Aphasia, Dysarthria, ALS, Speech and Language Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
50
Hangzhou
2026-03-15
Recruiting
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
NCT07412470Kidney Transplant Rejection
Sanofi
Phase 2/3
526
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Shanghai
2026-03-13
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Hefei, Shanghai, Guangzhou, Zhengzhou, Hangzhou, Nanjing, Xuzhou, Nanchang
2026-03-13
Recruiting
Utility of Whole Genome Sequencing in Fetuses With Abnormal Ultrasound Findings
NCT07606989Prenatal Diagnosis, Fetal Diseases
Women's Hospital School Of Medicine Zhejiang University
Observational
1,000
Hangzhou, Huzhou, Quzhou, Shaoxing
2026-03-12
Recruiting
A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advanced Solid Tumors
NCT07380334Advanced Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1
200
Hangzhou
2026-03-12
Recruiting
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195NAFLD and NASH, NAFLD( Non-alcoholic Fatty Liver Disease ), NAFLD Cirrhosis
The Affiliated Hospital of Hangzhou Normal University
Observational
20,000
Hangzhou
2026-03-12
Recruiting
A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children
NCT07402512Respiratory Syncytial Virus Infection
Simcere Pharmaceutical Co., Ltd
Phase 3
498
Xiamen, Changsha, Chengdu, Hangzhou
2026-03-11
Not yet open
A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis
NCT07298928Effectiveness
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
30
Shenzhen, Jinan, Hangzhou
2026-03-10
Active, closed
Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model "PANDAPro"
NCT06643715Pancreatic Cancer
Zhejiang University
Not applicable
100,000
Hangzhou
2026-03-07
Recruiting
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
NCT07319832Short Bowel Syndrome (SBS)
Takeda
Observational
12
Guangzhou, Shanghai, Hangzhou
2026-03-05
Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
NCT07438496Lupus Erythematosus, Systemic
Janssen Research & Development, LLC
Phase 3
600
Beijing, Changsha, Cheng Du Shi, Dongguan, Guangzhou, Hangzhou, Hefei, Jinhua
2026-03-05
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
NCT07284849CRC (Colorectal Cancer)
Incyte Corporation
Phase 3
700
Beijing, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou
2026-03-05
Recruiting
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
NCT07658534Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd.
Phase 2/3
290
Beijing, Guangzhou, Cangzhou, Nanyang, Zhengzhou, Wuhan, Hangzhou, Ruiโ€™an
2026-03-03
Recruiting
A Study of DXC014 in Patients With Advanced Solid Tumors.
NCT07177937Small Cell Lung Cancer, Melanoma, Prostate Cancer, Other Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
150
Beijing, Changsha, Nanchang, Qingdao, Hangzhou
2026-03-03
Not yet open
A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
NCT07357220Colorectal Cancer With Hepatic Metastases
Akeso
Phase 1/2
72
Hangzhou
2026-03-02
Recruiting
AI Assisted Screening for VHD Using Routine Chest CT Scans
NCT07449130Heart Valve Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
3,000
Wuhan, รœrรผmqi, Hangzhou
2026-03-02
Recruiting
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
NCT07444060CD - Crohn's Disease, Stricture; Bowel, IBD - Inflammatory Bowel Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
100
Hangzhou
2026-03-01
Not yet open
Xenon Therapy for Children With Autism Spectrum Disorder
NCT07435103Autism Spectrum Disorder (ASD), Autism
The Children's Hospital of Zhejiang University School of Medicine
Phase 1/2
72
Hangzhou
2026-03-01
Recruiting
Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis
NCT07491016Telitacicept, Treatment Compliance, Rheumatoid Arthritis
Zhejiang Provincial People's Hospital
Observational
30
Hangzhou
2026-03-01
Recruiting
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
NCT07396480Venentoclax, Myeloid Malignancies, Conditioning, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
First Affiliated Hospital of Zhejiang University
Phase 3
186
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Nanjing, Jinan, Hangzhou
2026-03-01
Not yet open
Natural Course of Congenital Hydronephrosis in Infants Aged 0-6 Months
NCT07382570Congenital Hydronephrosis, UTD Grading System, Natural Progression, Pediatric
The Children's Hospital of Zhejiang University School of Medicine
Observational
330
Hangzhou
2026-03-01
By invitation
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
NCT07103655Hypertrophic Cardiomyopathy (HCM)
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
132
Hangzhou
2026-03-01
By invitation
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
NCT07651176Acute Myeloid Leukemia, Lisaftoclax
First Affiliated Hospital of Zhejiang University
Phase 2/3
267
Hangzhou
2026-03-01
By invitation
Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy
NCT07651163Acute Myeloid Leukemia (AML), Lisaftoclax
First Affiliated Hospital of Zhejiang University
Phase 2/3
450
Hangzhou
2026-03-01
Recruiting
ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse
NCT07481669Lymphoma Patients With High-risk of Central Nervous System Relapse
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
45
Hangzhou
2026-03-01
Not yet open
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children
NCT07424040Crohn's Diseases, Crohn's Disease in Pediatric Patient
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
154
Kunming, Hangzhou, Jinhua, Wenzhou
2026-03-01
Rows per page Showing 201–300 of 1812
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,812 of those studies with a site in Hangzhou.

How many clinical trials are recruiting in Hangzhou?

1,096 of the 1,812 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 300 have not yet opened recruitment, 372 are active but closed to new participants, and 44 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.